Omkar Speciality Chemicals Ltd. Initiates Post-Insolvency Revival

Nine Months Ended Dec 31, 2025: ₹0 Revenue, ₹-1.26 Crore Loss
Resolution Plan: ₹26.65 Crore Total, ₹15.08 Crore Infused

Reader Takeaway: Capital infusion aids revival; zero revenue and auditor concerns remain.

What just happened

Omkar Speciality Chemicals Ltd. has commenced the implementation of its resolution plan following NCLT approval on July 31, 2025. The company reported zero revenue from operations for the nine months ended December 31, 2025, and a loss of ₹1.26 crore for the same period.

Why this matters

This marks a critical transition phase for the company as it emerges from insolvency. The successful execution of the resolution plan, including capital infusion and operational restart, is key to its future viability. Investors are watching for signs of stabilization and a return to profitability.

The backstory

Omkar Speciality Chemicals has undergone the Corporate Insolvency Resolution Process (CIRP). The NCLT's approval of the resolution plan is the first step towards restructuring and reviving the company's operations.

What changes now

New management, including a CEO and an Independent Director, has been appointed. Key committees like the Audit Committee have been reconstituted. A new bank account has been opened with ICICI Bank to facilitate daily transactions and business resumption. The resolution plan allocates ₹26.65 crore, with ₹23.14 crore for creditors and ₹3.51 crore for capex and working capital.

Risks to watch

The statutory auditors have issued a qualified conclusion, citing a material uncertainty regarding the company's ability to continue as a going concern. This is due to historical losses and a negative net worth, underscoring the challenges in turning the business around.

Peer comparison

(No peer comparison data available in the filing)

Context metrics (time-bound)

• Resolution Plan Approval: July 31, 2025
• Reporting Period: Nine Months Ended December 31, 2025
• Funds Infused by Resolution Applicant: ₹15.08 crore (as of Dec 2025)
• Total Resolution Amount: ₹26.65 crore

What to track next

Investors should closely monitor the company's progress in restarting revenue-generating operations, the effective deployment of the infused capital, and future financial performance updates. The management's ability to address the going concern risk flagged by auditors will be crucial.